cancer prostate treatment » Blog Archive » Prostate Cancer Treatment Side Effects
Links shared publicly online about this topic.
- 923total visits
cancer prostate treatment » Blog Archive » Prostate Cancer Treatment Side Effects
cancer-prostate-treatment.tingza.net —
View full resource at cancer-prostate-treatment.tingza.net
Tags: Cancer, Prostate Cancer, Prostate, Men's Health
Most Recently Shared on August 24, 2010 at 11:08 pm By:
cancer prostate treatment » Blog Archive » Prostate Cancer ... http://bit.ly/cUYcmd
Identifying A Molecular-Based Treatment For A Viral Skin Cancer
medicalnewstoday.com — “Four years after they discovered the viral roots of a rare skin cancer, researchers at the University of Pittsburgh Cancer Institute (UPCI) and the School of Medicine have now identified a molecul” View full resource at medicalnewstoday.com
Most Recently Shared on May 11, 2012 at 7:05 am By:
Identifying A Molecular-Based Treatment For A Viral Skin Cancer http://t.co/reDzqgWe #viruses #bacteria
Salivary Gland Damage In Head And Neck Cancer May Be Avoided By Stem Cell Sparing Radiotherapy
medicalnewstoday.com — “Researchers believe they may have found a way to avoid damaging salivary glands during radiotherapy treatment for head and neck cancer - a discovery that could improve the quality of life of 500,0” View full resource at medicalnewstoday.com
Most Recently Shared on May 11, 2012 at 7:05 am By:
Salivary Gland Damage In Head And Neck Cancer May Be Avoided By Stem Cell Sparing Radiotherapy http://t.co/sAUMqroT #entnews
Exhaustion Renders Immune Cells Less Effective In Cancer Treatment
medicalnewstoday.com — “Rather than stimulating immune cells to more effectively battle cancerous tumors, treatment with the protein interleukin-12 (IL-12) has the opposite effect, driving these intracellular fighters to” View full resource at medicalnewstoday.com
Most Recently Shared on May 11, 2012 at 7:05 am By:
Exhaustion Renders Immune Cells Less Effective In Cancer Treatment http://t.co/DYGGZ70P #vaccines #immunesystem
Update on Kinase Inhibitors for CLL: Where Are We Now?
oncologytube.com — “Update on Kinase Inhibitors for CLL: Where Are We Now?: Kinase inhibitors, a newer approach to fighting blood cancers, have been making major strides throughout 2011 for the treatment of CLL. Dr. Susan O'Brien, an investigator of this approach, gives us a...” View full resource at oncologytube.com
Most Recently Shared on May 8, 2012 at 10:29 pm By:
Fewer Complications, Better Outcomes with Robot-Assisted Prostate Cancer Surgery
newswise.com — “Robot-assisted surgery is now both more common and far more successful than radical “open” surgery to treat prostate cancer in the United States, according to a new Henry Ford Hospital study published in the current issue of the medical journal European Urology.” View full resource at newswise.com
Most Recently Shared on May 8, 2012 at 1:02 pm By:
@HenryFordNews: Fewer Complications, Better Outcomes with Robot-Assisted #Prostate #Cancer #Surgery http://t.co/dNyDOeD6
Younger And At-Risk Men Benefit From PSA Screening To Detect Prostate Cancer
medicalnewstoday.com — “Screening younger men and men at risk of prostate cancer can be beneficial in reducing metastatic cancer and deaths and should not be abandoned, states an article published in CMAJ (Canadian Me” View full resource at medicalnewstoday.com
Most Recently Shared on May 8, 2012 at 11:05 am By:
Younger And At-Risk Men Benefit From PSA Screening To Detect Prostate Cancer http://t.co/8p7fHau8 #prostate
In Prostate Cancer, Genetic Abnormalities In Benign Or Malignant Tissues Predict Relapse
medicalnewstoday.com — “While active monitoring of serum prostate specific antigen (PSA) levels in men over 50 has greatly improved early detection of prostate cancer, prediction of clinical outcomes after diagnosis rema” View full resource at medicalnewstoday.com
Most Recently Shared on May 8, 2012 at 10:05 am By:
In Prostate Cancer, Genetic Abnormalities In Benign Or Malignant Tissues Predict Relapse http://t.co/OfzWAbaY #prostate
Potential New Treatments for Oral Squamous Cell Carcinoma in Cats
pet-health-care-gazette.com — “New research developments for feline oral squamous cell carcinoma, a common cancer of the mouth in cats.” View full resource at pet-health-care-gazette.com
Most Recently Shared on May 8, 2012 at 4:02 am By:
Potential New Treatment Options for Mouth Cancer (Oral Squamous Cell Carcinoma) in Cats: New resea... http://t.co/wCJP1F6m @LorieAHuston
Medical News: Docs May Resist PSA Screening Recommendations - in Oncology/Hematology, Prostate Cancer from MedPage Today
medpagetoday.com — “Medical News: Docs May Resist PSA Screening Recommendations - in Oncology/Hematology, Prostate Cancer from MedPage Today” View full resource at medpagetoday.com
Most Recently Shared on May 8, 2012 at 2:15 am By:
PSA testing. "The chains of habit are too weak to be felt until they are too strong to be broken." You take the... http://t.co/srUs9sTq
Curry Ingredient May Have Cancer Treatment Benefits
medicalnewstoday.com — “New evidence, studied by researchers in the Department of Cancer Studies and Molecular Medicine, at the University of Leicester, reveals that curcumin, found in the curry ingredient turmeric,” View full resource at medicalnewstoday.com
Most Recently Shared on May 7, 2012 at 10:05 pm By:
Does Curcumin Have Cancer Treatment Benefits? http://t.co/oiA6uFyG #cancer
Scientists Identify Prostate Cancer Stem Cells Among Low-PSA Cells - MD Anderson Cancer Center
mdanderson.org — “Cells resist hormone inhibition and chemotherapy; video captures production of other cell types” View full resource at mdanderson.org
Most Recently Shared on May 7, 2012 at 8:37 pm By:
Scientists Identify Prostate Cancer Stem Cells Among Low-PSA Cells - MD Anderson Cancer Center: http://t.co/jR68cLcP
Immunotherapy Drugs: Two Drugs Harness Immune System To Fight Cancer
huffingtonpost.com — “By Bill Berkrot NEW YORK, May 7 (Reuters) - More than 100 years after researchers first explored the potential to harness the body's immune system to fight cancer, the field's leading doctors see the concept finally proving itself on a large scale in the next year or two. Two drugs based on immunotherapy are already available and have met with mixed results. Bristol-Myers Squibb's Yervoy has been hailed as a major breakthrough for treatment of melanoma since its approval last year, w” View full resource at huffingtonpost.com
Most Recently Shared on May 7, 2012 at 8:30 pm By:
Immunotherapy Drugs: Two Drugs Harness Immune System To Fight #Cancer http://t.co/KXQ728T9 via @HealthyLiving
OPKO Health Enters into License Agreement with International Health Technology for Next Generation Prostate Cancer Biomarker Panel | Biomarker Commons
feeds.feedblitz.com — “OPKO Health, Inc. (NYSE:OPK) today announced execution of a license agreement granting International Health Technology, Ltd. (Cambridge, England) the right to offer OPKO's novel panel of kallikrein biomarkers and associated algorithm for the detection of prostate cancer in a laboratory setting in the U.K., Ireland, Sweden and Denmark.” View full resource at feeds.feedblitz.com
Most Recently Shared on May 7, 2012 at 8:07 pm By:
Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets
newswise.com — “A new analysis concludes that rituximab, a drug commonly used to treat blood cancers, leads to treatment responses lasting at least five years in approximately one quarter of patients with low platelet counts and a risk of bleeding due to chronic immune thrombocytopenic purpura (ITP). In study results published online today in Blood, the Journal of the American Society of Hematology (ASH), investigators at Weill Cornell Medical College provide the very first long-term outcome data for patients w” View full resource at newswise.com
Most Recently Shared on May 7, 2012 at 4:44 pm By:
#health news: Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets http://t.co/ebFOkm4e
Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT... -- SUNNYVALE, Calif., April 26, 2012 /PRNewswire/ --
prnewswire.com — “Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer. New Randomized Study Aims to Provide Comparative Evidence to Support CyberKnife SBRT as the Gold Standard Treatment for Prostate Cancer.” View full resource at prnewswire.com
Most Recently Shared on May 7, 2012 at 4:02 pm By:
@Accuray Study Compares CyberKnife® SBRT to Surgery & IMRT for Treatment of Early-Stage #Prostate #Cancer http://t.co/2Rwp4khM
Advertisement

